We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Mojdeh Heavner

Mojdeh S. Heavner PharmD, BCPS, BCCCP, FCCM

Associate Professor and Vice Chair for Clinical Services, Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy; Clinical Pharmacy Specialist, Medical Intensive Care Unit, University of Maryland Medical Center, Baltimore, Maryland

Mojdeh Heavner, PharmD, BCPS, BCCCP, FCCM, is an Associate Professor and Vice Chair for Clinical Services in the Department of Pharmacy Practice and Science at the University of Maryland School of Pharmacy in Baltimore, MD and serves as the Coordinator for the Pharmacotherapy Residency Program.

She completed her undergraduate studies at the University of Maryland College Park and Pharm.D. degree at the University of Maryland School of Pharmacy. Dr. Heavner completed residencies in pharmacy practice and critical care and solid organ transplant at Yale New Haven Hospital. She worked at Yale New Haven as the Medical ICU Clinical Pharmacy Specialist, Supervisor of Clinical Pharmacy Services, and Residency Program Director of Critical Care. Mojdeh practices in a 29-bed Medical ICU at the University of Maryland Medical Center. Her interests include sleep and delirium in the ICU, pharmacokinetic and pharmacodynamic changes in critical illness, and recently, she has been involved in scholarship and education related to the COVID-19 pandemic.

Disclosures

Dr. Heavner has no relevant disclosures.